CORVUS PHARMACEUTICALS INC (CRVS) Forecast, Price Target & Analyst Ratings

NASDAQ:CRVS • US2210151005

Current stock price

16.02 USD
-1.83 (-10.25%)
At close:
17.04 USD
+1.02 (+6.37%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CORVUS PHARMACEUTICALS INC (CRVS).

Forecast Snapshot

Consensus Price Target

Price Target
$35.87
+ 123.91% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.15
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.15%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$35.87
Upside
+ 123.91%
From current price of $16.02 to mean target of $35.87, Based on 13 analyst forecasts
Low
$27.27
Median
$32.13
High
$53.55

Price Target Revisions

1 Month
0.48%
3 Months
129.35%

Price Target Summary

13 Wall Street analysts provided a forecast for the next 12 months for CRVS. The average price target is 35.87 USD. This implies a price increase of 123.91% is expected in the next year compared to the current price of 16.02.
The average price target has been revised upward by 129.35% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CRVS Current Analyst RatingCRVS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

CRVS Historical Analyst RatingsCRVS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
86.15%
CRVS was analyzed by 13 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about CRVS.
In the previous month the buy percentage consensus was at a similar level.
CRVS was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-17Goldman SachsInitiate Buy
2026-03-13OppenheimerReiterate Outperform -> Outperform
2026-01-22JefferiesMaintains Buy -> Buy
2026-01-21OppenheimerMaintains Outperform -> Outperform
2026-01-21BarclaysMaintains Overweight -> Overweight
2026-01-20HC Wainwright & Co.Maintains Buy -> Buy
2025-10-13BarclaysInitiate Overweight
2025-05-20MizuhoMaintains Outperform -> Outperform
2025-05-09OppenheimerReiterate Outperform -> Outperform
2025-03-26OppenheimerMaintains Outperform -> Outperform
2025-03-26HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-14HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-02HC Wainwright & Co.Initiate Buy
2024-11-13OppenheimerReiterate Outperform -> Outperform
2024-09-16Ladenburg ThalmannMaintains Buy -> Buy
2024-05-07OppenheimerMaintains Outperform -> Outperform
2024-04-01Cantor FitzgeraldReiterate Overweight
2024-03-27MizuhoMaintains Neutral -> Neutral
2024-03-20OppenheimerMaintains Outperform -> Outperform
2023-09-07Cantor FitzgeraldReiterate Overweight -> Overweight
2023-06-16MizuhoReiterate Neutral -> Neutral
2023-05-30Ladenburg ThalmannMaintains Buy -> Buy
2023-05-09Cantor FitzgeraldMaintains Overweight
2023-03-30MizuhoReiterate Neutral
2022-10-07Ladenburg ThalmannInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.15
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-172.16%
Number of Analysts
9

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-5.05%
EPS (3 Months)
-7.27%

Next Earnings Summary

CRVS is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.15 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CRVS revenue by date.CRVS revenue by date.
N/AN/AN/A
387.19%		N/A
142.47%		N/A
111.64%		N/A
131.04%		N/A
69.00%		N/A
14.47%
EBITDA
YoY % growth
CRVS ebitda by date.CRVS ebitda by date.
-13.62M-36.39M
-167.18%		-55.68M
-53.01%		-48.37M
13.13%		-48.11M
0.54%		-43.13M
10.35%		-38.17M
11.50%		-32.2M
15.64%		-23.256M
27.78%		-27.463M
-18.09%		-42.866M
-56.09%		N/A
-28.49%		N/A
-20.37%		N/A
-16.92%		N/A
248.43%		N/A
121.18%		N/A
33.75%		N/A
72.16%		N/A
16.87%
EBIT
YoY % growth
CRVS ebit by date.CRVS ebit by date.
-13.77M-36.98M
-168.55%		-56.52M
-52.84%		-49.22M
12.92%		-48.85M
0.75%		-43.76M
10.42%		-38.63M
11.72%		-32.57M
15.69%		-23.407M
28.13%		-27.548M
-17.69%		-42.971M
-55.99%		N/A
-48.64%		N/A
-10.84%		N/A
21.49%		N/A
93.26%		N/A
2,017.30%		N/A
272.08%		N/A
110.23%		N/A
70.84%
Operating Margin
CRVS operating margin by date.CRVS operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
CRVS eps by date.CRVS eps by date.
N/A-6.88-2.72
60.47%		-1.75
35.66%		-1.59
9.14%		-1.46
8.18%		-1.06
27.40%		-0.89
16.04%		-0.57
35.96%		-0.94
-64.91%		-0.16
82.98%		N/A
-342.97%		N/A
-11.78%		N/A
3.44%		N/A
114.67%		N/A
857.55%		N/A
130.70%		N/A
65.84%		N/A
75.81%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.15
-172.16%		-0.16
-63.34%		-0.18
-54.10%		-0.21
-38.72%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-14.265M
-43.77%		-16.857M
-64.29%		-19.073M
-80.41%		-21.748M
-78.01%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CRVS Yearly Revenue VS EstimatesCRVS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
CRVS Yearly EPS VS EstimatesCRVS Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-68.47%
EPS Next 5 Year
54.19%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-22.38%
EBIT Next 5 Year
51.64%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CORVUS PHARMACEUTICALS INC / CRVS Forecast FAQ

What is the price target for CRVS stock?

13 analysts have analysed CRVS and the average price target is 35.87 USD. This implies a price increase of 123.91% is expected in the next year compared to the current price of 16.02.

When does CORVUS PHARMACEUTICALS INC (CRVS) report earnings?

CORVUS PHARMACEUTICALS INC (CRVS) will report earnings on 2026-05-11.

What are the consensus estimates for CRVS stock next earnings?

The consensus EPS estimate for the next earnings of CORVUS PHARMACEUTICALS INC (CRVS) is -0.15 USD and the consensus revenue estimate is 0 USD.